Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosie Upstill-Goddard

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
STAR Protocols|October 28, 2020
Using Chromatin Accessibility to Delineate Therapeutic Subtypes in Pancreatic Cancer Patient-Derived Cell LinesHolly Brunton, Ian M Garner, Ulla-Maja Bailey, et al.
Gut|March 28, 2023
FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancerMarta Canel, Aleksandra Dominika Sławińska, David W Lonergan, et al.
British Journal of Cancer|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinomaKatharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
Frontiers in Oncology|July 11, 2024
Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroupsAlessandra Pulvirenti, Marialuisa Barbagallo, Anna Rita Putignano, et al.
Annals of Surgery|February 6, 2023
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic CancerStephan B Dreyer, Sarah Rae, Kirsty Bisset, et al.
Nature Communications|March 3, 2026
Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreasAntonio Pea, Xiaotong He, Rosie Upstill-Goddard, et al.
Gut|September 27, 2023
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapyColm J O'Rourke, Massimiliano Salati, Colin Rae, et al.
Nature Communications|November 19, 2021
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damagePietro Carotenuto, Francesco Amato, Andrea Lampis, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
A novel DNA repair protein, N-Myc downstream regulated gene 1 (NDRG1), links stromal tumour microenvironment to chemoresistanceNina Kozlova, Kayla A Cruz, Hanna M Doh, et al.
Nature Cell Biology|April 27, 2026
Cancer-associated fibroblasts regulate DNA repair in pancreatic cancer through NDRG1-mediated R-loop processingNina Kozlova, Kayla A Cruz, Antoine A Ruzette, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
STAR Protocols|October 28, 2020
Using Chromatin Accessibility to Delineate Therapeutic Subtypes in Pancreatic Cancer Patient-Derived Cell LinesHolly Brunton, Ian M Garner, Ulla-Maja Bailey, et al.
Gut|March 28, 2023
FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancerMarta Canel, Aleksandra Dominika Sławińska, David W Lonergan, et al.
British Journal of Cancer|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinomaKatharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
Frontiers in Oncology|July 11, 2024
Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroupsAlessandra Pulvirenti, Marialuisa Barbagallo, Anna Rita Putignano, et al.
Annals of Surgery|February 6, 2023
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic CancerStephan B Dreyer, Sarah Rae, Kirsty Bisset, et al.
Nature Communications|March 3, 2026
Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreasAntonio Pea, Xiaotong He, Rosie Upstill-Goddard, et al.
Gut|September 27, 2023
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapyColm J O'Rourke, Massimiliano Salati, Colin Rae, et al.
Nature Communications|November 19, 2021
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damagePietro Carotenuto, Francesco Amato, Andrea Lampis, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
A novel DNA repair protein, N-Myc downstream regulated gene 1 (NDRG1), links stromal tumour microenvironment to chemoresistanceNina Kozlova, Kayla A Cruz, Hanna M Doh, et al.
Nature Cell Biology|April 27, 2026
Cancer-associated fibroblasts regulate DNA repair in pancreatic cancer through NDRG1-mediated R-loop processingNina Kozlova, Kayla A Cruz, Antoine A Ruzette, et al.
Pageof 2